Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients-Reference-Cited by-同舟云学术

Bepridil in combination with anthracyclines to reverse anthracycline resistance in cancer patients

Published:1991-06 Issue:6 Volume:27 Page:739-744
ISSN:0277-5379
Container-title:European Journal of Cancer and Clinical Oncology
language:en
Short-container-title:European Journal of Cancer and Clinical Oncology

Author:

van Kalken Coenraad K.,van der Hoeven Jacobus J.M.,de Jong Jan,Giaccone Giuseppe,Schuurhuis Gerrit Jan,Maessen Paul A.,Blokhuis Wouter M.D.,van der Vijgh Wim J.F.,Pinedo Herbert M.

Publisher

Elsevier BV

Subject

Oncology

Reference38 articles.

1. Reduced drug accumulation in multiple drug resistant human KB carcinoma cell lines;Fojo;Cancer Res,1985

2. Daunomycin accumulation in resistant tumor cells as a screening model for resistance modifying drugs: role of protein binding;Broxterman;Cancer Lett,1987

3. Quantitative determination of factors contributing to doxorubicin resistance in multidrug-resistant cells;Schuurhuis;J Natl Cancer Inst,1989

4. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines;Kartner;Science,1983

5. ATP-dependent transport of vinblastine in vesicles from human multidrug resistant cells;Horio,1988

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug candidate for the treatment of several soft‑tissue sarcoma histologic subtypes: A computational method using survival‑associated gene signatures for drug repurposing;Oncology Reports;2019-02-26

2. Bepridil exhibits anti-leukemic activity associated with NOTCH1 pathway inhibition in chronic lymphocytic leukemia;International Journal of Cancer;2018-03-23

3. Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds;Current Medicinal Chemistry;2012-03-01

4. Targeting MDR in breast and lung cancer: Discriminating its potential importance from the failure of drug resistance reversal studies;Drug Resistance Updates;2012-02

5. Biotechnical Drugs as Antitumor Agents;Biotechnology;2008-05-28